FUNDAMENTALS · Fundamentals · CN Healthcare

WORK Medical Technology Group (WOK) Fundamentals 2026 — Revenue Analysis | SniperIQ

WORK Medical Technology Group (WOK) is a CN-listed Healthcare company in Medical - Specialties with a market capitalization of $4M, trading at

.86 on the NASDAQ. This SniperIQ fundamentals page covers WORK Medical Technology Group's valuation, profitability (net margin -10.9%), revenue (
0M in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.

Market Cap$4M
Net Margin-10.9%
Revenue (FY25)
0M

Full research coverage

  • 8-Quarter Revenue & Margin Trend
  • Debt Maturity & Coverage
  • Peer Valuation Comparison
  • Free Cash Flow & Owner Earnings
  • AI Signal + Institutional Flow
  • DCF Valuation Model

Frequently Asked Questions

What is WORK Medical Technology Group's market cap?

WORK Medical Technology Group (WOK) has a market capitalization of approximately $4M, trading at

.86 on the NASDAQ. Market cap moves with the live share price.

What is WORK Medical Technology Group's P/E ratio?

WORK Medical Technology Group's trailing twelve-month P/E ratio is not meaningful (negative or nil earnings), with a price-to-book (P/B) of 0.0x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.

How profitable is WORK Medical Technology Group?

WORK Medical Technology Group runs a net profit margin of -10.9%, a gross margin of 23.8%, and an operating margin of -25.3%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.

How much revenue does WORK Medical Technology Group generate?

WORK Medical Technology Group reported revenue of

0M for fiscal year 2025, with net income of -
M and earnings per share (EPS) of -37.010000000000005. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.

Does WORK Medical Technology Group pay a dividend?

WORK Medical Technology Group does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.

Is WORK Medical Technology Group financially healthy?

WORK Medical Technology Group carries a debt-to-equity ratio of 0.35x and a current ratio of 1.71x, with a market beta of 2.66. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.

Is WORK Medical Technology Group a good stock to buy in 2026?

SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For WORK Medical Technology Group (WOK) the key facts are: market cap $4M, revenue

0M, 52-week range 1.78-930000. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.

Track WORK Medical Technology Group's full fundamentals live

Get WORK Medical Technology Group's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.

Related: Mustang Bio (MBIO) fundamentals · Revelation Biosciences (REVB) fundamentals · Indaptus Therapeutics (INDP) fundamentals · BioAtla (BCAB) fundamentals · All stock fundamentals · AI signal library
Research Hubs: Fundamentals library · Screeners · Institutional positioning · Super investors · Daily signals · Platform comparisons